Mutations in specific genes associated with higher circulating tumor fractions in patients—this was statistically significant for the most prevalent mutations, in PIK3CA, TP53, and ESR1, most likely simply demonstrating that higher circulating tumor fraction means mutation detection in ctDNA is more likely (Supplementary Figure 8, available online). This evidence concerns the gene PIK3CA and neoplasm.